Global Extracorporeal Membrane Oxygenation Machine Market Size, Share, Forecast Report, 2020-2027

The global Extracorporeal Membrane Oxygenation Machine market garnered revenue around USD 0.4 Billion in 2019 and projected to reach USD 0.6 Billion in 2027, with at a compound annual growth rate (CAGR) 5.5% throughout the estimate period from 2020 to 2027.

Extracorporeal membrane oxygenation system is used for the patient suffering from heart failure and lung failure. Extracorporeal membrane oxygenation refers to one of the extracorporeal lung assist (ECLA) technologies, primarily adopted to partially or completely replace the cardiopulmonary function of patients to protect the oxygen supply of the organs and strive for time to treat primary diseases

The world is currently experiencing the pandemic of an infectious disease called COVID-19. Government is taking initiatives to address these urgent public health concerns by helping to increase the availability of products and expanding the indication of extracorporeal membrane oxygen system. For instance, for the treatment of COVID-19, China Ministry of Health guidelines consider that extracorporeal membrane oxygenation (ECMO) can act as a salvage treatment measure. This in turn to creates significant opportunity in the extracorporeal membrane oxygenation machine market

The extracorporeal membrane oxygenation machine market is currently a booming one, owing to current exceptional crisis scenario of the COVID-19 pandemic.

North America dominate the global extracorporeal membrane oxygenation machine market in 2019 and the trend is anticipated to continue during the forecast period. The growth of market in the region is attributed due to well established healthcare infrastructure and presence of large number of extracorporeal life support organizations.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Extracorporeal Membrane Oxygenation Machine market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Extracorporeal Membrane Oxygenation Machine market growth.

The global Extracorporeal Membrane Oxygenation Machine market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

 Key players in the global extracorporeal membrane oxygenation machine market include Terumo Corporation, Medtronic plc, Getinge AB, LivaNova PLC, Nipro Corporation, MicroPort Scientific Corporation, XENIOS AG,  OriGen Biomedical, EUROSETS and Hemovent GmbH

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

• Global Extracorporeal Membrane Oxygenation Machine Market, by Component Type
  • Pumps
    • Roller Pumps
    • Centrifugal Pumps
  • Oxygenators
  • Heat Exchangers
  • Saturation Monitors
  • Others
• Global Extracorporeal Membrane Oxygenation Machine Market, by Application
  • Respiratory
  • Cardiology
  • Extracorporeal Cardiopulmonary Resuscitation
• Global Extracorporeal Membrane Oxygenation Machine Market, by Modality
  • Venoarterial
  • Venovenous
  • Arteriovenous

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA